Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Romidepsin-induced durable remission for relapsed nodal peripheral T-cell lymphoma with T follicular helper phenotype after allogeneic hematopoietic cell transplantation.
Tao K, Inamoto Y, Furukawa H, Hosoba R, Takeda W, Maeshima A, Aoki J, Ito A, Tanaka T, Kim SW, Makita S, Fukuhara S, Kogure Y, Kataoka K, Izutsu K, Fukuda T. Tao K, et al. Among authors: takeda w. Int J Hematol. 2023 Aug;118(2):292-298. doi: 10.1007/s12185-023-03561-7. Epub 2023 Feb 20. Int J Hematol. 2023. PMID: 36807258
Association of Cumulative Steroid Dose with Risk of Infection after Treatment for Severe Acute Graft-versus-Host Disease.
Matsumura-Kimoto Y, Inamoto Y, Tajima K, Kawajiri A, Tanaka T, Hirakawa T, Ino K, Asao Y, Tamogami H, Kono C, Takeda W, Okinaka K, Fuji S, Kurosawa S, Kim SW, Tanosaki R, Yamashita T, Fukuda T. Matsumura-Kimoto Y, et al. Among authors: takeda w. Biol Blood Marrow Transplant. 2016 Jun;22(6):1102-1107. doi: 10.1016/j.bbmt.2016.02.020. Epub 2016 Mar 8. Biol Blood Marrow Transplant. 2016. PMID: 26968790 Free article.
[Successful treatment of very severe late-onset sinusoidal obstruction syndrome with recombinant human soluble thrombomodulin, steroids, and control of intra-abdominal pressure].
Hirakawa T, Tanaka T, Matsumi J, Takeda W, Kim SW, Inamoto Y, Ito A, Yamaguchi K, Ishimaru S, Kumamoto T, Arakawa A, Sugiyama M, Dan L, Shigematsu M, Sato T, Ogawa C, Fukuda T. Hirakawa T, et al. Among authors: takeda w. Rinsho Ketsueki. 2020;61(7):734-739. doi: 10.11406/rinketsu.61.734. Rinsho Ketsueki. 2020. PMID: 32759558 Japanese.
Effect of donor type on volume of blood transfusions required after allogeneic hematopoietic cell transplantation.
Kurosawa S, Yamaguchi T, Nakabayashi S, Kasane M, Tsubokura M, Iwashita N, Minakawa Y, Ohtake R, Kawamura K, Nishioka Y, Takeda W, Hirakawa T, Aoki J, Ito A, Tanaka T, Inamoto Y, Kim SW, Kojima M, Takanashi M, Fukuda T. Kurosawa S, et al. Among authors: takeda w. Int J Hematol. 2021 Apr;113(4):518-529. doi: 10.1007/s12185-020-03041-2. Epub 2021 Jan 3. Int J Hematol. 2021. PMID: 33392973
Adenovirus disease after hematopoietic cell transplantation: A Japanese transplant registry analysis.
Inamoto Y, Takeda W, Hirakawa T, Sakaguchi H, Nakano N, Uchida N, Doki N, Ikegame K, Katayama Y, Sawa M, Kuriyama T, Hiramoto N, Ota S, Ozawa Y, Kataoka K, Kanda Y, Hino M, Kimura T, Atsuta Y, Fukuda T, Nagafuji K. Inamoto Y, et al. Among authors: takeda w. Am J Hematol. 2022 Dec;97(12):1568-1579. doi: 10.1002/ajh.26723. Epub 2022 Sep 19. Am J Hematol. 2022. PMID: 36087061 Free article.
Analysis of risk factors for fatal renal complications after allogeneic hematopoietic cell transplantation.
Yanagisawa R, Koyama H, Yakushijin K, Uchida N, Jinguji A, Takeda W, Nishida T, Tanaka M, Eto T, Ohigashi H, Ikegame K, Matsuoka KI, Katayama Y, Kanda Y, Sawa M, Kawakita T, Onizuka M, Fukuda T, Atsuta Y, Shinohara A, Nakasone H. Yanagisawa R, et al. Among authors: takeda w. Bone Marrow Transplant. 2024 Mar;59(3):325-333. doi: 10.1038/s41409-023-02172-4. Epub 2023 Dec 16. Bone Marrow Transplant. 2024. PMID: 38104219
Impact of stem cell selection between bone marrow and peripheral blood stem cells for unrelated hematopoietic stem cell transplantation for hematologic malignancies: on behalf of the Donor/Source Working Group of the Japanese Society for Transplantation and Cellular Therapy.
Hayashi H, Iwasaki M, Nakasone H, Tanoshima R, Shimabukuro M, Takeda W, Nishida T, Kako S, Fujiwara SI, Katayama Y, Sawa M, Serizawa K, Matsuoka KI, Uchida N, Ikeda T, Ohigashi H, Fukushima K, Hino M, Kanda Y, Fukuda T, Atsuta Y, Kanda J. Hayashi H, et al. Among authors: takeda w. Cytotherapy. 2024 Feb;26(2):178-184. doi: 10.1016/j.jcyt.2023.11.012. Epub 2023 Dec 16. Cytotherapy. 2024. PMID: 38108686
53 results